Actamax Surgical Materials, a DSM-DuPont joint venture, said today that it submitted an Investigational Device Exemption application to the FDA for its adhesion barrier device in gynecological laparoscopic surgery. Adhesions, excessive scar tissue that can form between adjacent internal tissues, are a result of normal wound healing. Adhesions occur post-surgical operations at rates of 50-90%. […]
Actamax Surgical Materials
Actamax touts clinical data for sprayable adhesion barrier device
Actamax Surgical Materials, a DSM-DuPont joint venture, touted data from a 12-month clinical follow-up study evaluating the effects of its biocompatible, resorbable adhesion barrier device. The results were presented this week at the 45th Global Congress on Minimally Invasive Gynecology in Orlando, Fla. Adhesions, excessive scar tissue that can form between adjacent internal tissues, are […]